Dian D - Search Results

1

Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.

Jeschke U, Wiest I, Schumacher AL, Kupka M, Rack B, Stahn R, Karsten U, Mayr D, Friese K, Dian D. Jeschke U, et al. Among authors: dian d. Anticancer Res. 2012 May;32(5):2185-9. Anticancer Res. 2012. PMID: 22593508

2

Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.

Mylonas I, Mayr D, Walzel H, Shabani N, Dian D, Kuhn C, Kunze S, Jeschke U, Friese K. Mylonas I, et al. Among authors: dian d. Anticancer Res. 2007 Jul-Aug;27(4A):1975-80. Anticancer Res. 2007. PMID: 17649808 Free article.

3

Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.

Dian D, Janni W, Kuhn C, Mayr D, Karsten U, Mylonas I, Friese K, Jeschke U. Dian D, et al. Onkologie. 2009 May;32(5):238-44. doi: 10.1159/000209280. Epub 2009 Apr 20. Onkologie. 2009. PMID: 19420969 Free article.

4

Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.

Weissenbacher T, Kuhn C, Mayr D, Pavlik R, Friese K, Scholz C, Jeschke U, Ditsch N, Dian D. Weissenbacher T, et al. Among authors: dian d. Anticancer Res. 2011 Feb;31(2):451-7. Anticancer Res. 2011. PMID: 21378323

5

Expression of different carbohydrate tumour markers and galectins 1 and 3 in normal squamous and malignant epithelia of the upper aaerodigestive tract.

Wiest I, Alexiou C, Kuhn C, Schulze S, Kunze S, Mayr D, Betz P, Jeschke U, Dian D. Wiest I, et al. Among authors: dian d. Anticancer Res. 2012 May;32(5):2023-9. Anticancer Res. 2012. PMID: 22593483

6

Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.

Dian D, Lenhard M, Mayr D, Heublein S, Karsten U, Goletz S, Kuhn C, Wiest I, Friese K, Weissenbacher T, Jeschke U. Dian D, et al. Histol Histopathol. 2013 Feb;28(2):239-44. doi: 10.14670/HH-28.239. Histol Histopathol. 2013. PMID: 23275306

7

Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX™ Antibody in Malignant and Normal Tissues of the Head and Neck.

Wiest I, Alexiou C, Friese K, Betz P, Tübel J, Goletz S, Dian D, Jeschke U. Wiest I, et al. Among authors: dian d. Anticancer Res. 2016 Jun;36(6):3179-84. Anticancer Res. 2016. PMID: 27272845

8

Expression of cathepsin-D in primary breast cancer and corresponding local recurrence or metastasis: an immunohistochemical study.

Dian D, Vrekoussis T, Shabani N, Mylonas I, Kuhn C, Schindlbeck C, Navrozoglou I, Friese K, Makrigiannakis A, Jeschke U. Dian D, et al. Anticancer Res. 2012 Mar;32(3):901-5. Anticancer Res. 2012. PMID: 22399610

9

The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.

Hoeing A, Kuhn C, Shabani N, Schulze S, Gingelmaier A, Dian D, Jeschke U, Friese K, Mylonas I. Hoeing A, et al. Among authors: dian d. Anticancer Res. 2007 Jul-Aug;27(4A):2005-10. Anticancer Res. 2007. PMID: 17649813 Free article.

10

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR).

Heublein S, Vrekoussis T, Mayr D, Friese K, Lenhard M, Jeschke U, Dian D. Heublein S, et al. Among authors: dian d. J Ovarian Res. 2013 Jan 22;6(1):6. doi: 10.1186/1757-2215-6-6. J Ovarian Res. 2013. PMID: 23339713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters